Jamie Samath Sells 269 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) insider Jamie Samath sold 269 shares of the company’s stock in a transaction on Monday, November 11th. The stock was sold at an average price of $539.89, for a total value of $145,230.41. Following the transaction, the insider now directly owns 8,757 shares in the company, valued at approximately $4,727,816.73. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link.

Jamie Samath also recently made the following trade(s):

• On Friday, November 8th, Jamie Samath sold 22,903 shares of Intuitive Surgical stock. The shares were sold at an average price of $525.00, for a total transaction of $12,024,075.00.

Intuitive Surgical Trading Up 0.2 %

NASDAQ ISRG traded up $1.32 during trading on Tuesday, reaching $537.07. The company’s stock had a trading volume of 1,455,926 shares, compared to its average volume of 1,459,553. The business has a 50-day moving average price of $494.78 and a 200-day moving average price of $453.94. Intuitive Surgical, Inc. has a 1-year low of $281.12 and a 1-year high of $542.59. The stock has a market capitalization of $191.29 billion, a PE ratio of 86.13, a PEG ratio of 5.27 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The business had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. As a group, analysts expect that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Hedge Funds Weigh In On Intuitive Surgical

Institutional investors and hedge funds have recently bought and sold shares of the stock. Ridgewood Investments LLC bought a new stake in shares of Intuitive Surgical in the 2nd quarter valued at approximately $26,000. Godsey & Gibb Inc. increased its holdings in Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares in the last quarter. Creekmur Asset Management LLC increased its holdings in Intuitive Surgical by 200.0% during the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 42 shares in the last quarter. LGT Financial Advisors LLC grew its holdings in shares of Intuitive Surgical by 415.4% in the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock valued at $30,000 after acquiring an additional 54 shares in the last quarter. Finally, MidAtlantic Capital Management Inc. bought a new position in shares of Intuitive Surgical in the 3rd quarter valued at about $33,000. Institutional investors own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on ISRG shares. Robert W. Baird boosted their price objective on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a report on Thursday, October 17th. BTIG Research set a $535.00 price target on shares of Intuitive Surgical in a research report on Friday, October 18th. Evercore ISI reiterated a “cautious” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Stifel Nicolaus increased their price objective on shares of Intuitive Surgical from $475.00 to $525.00 and gave the stock a “buy” rating in a research report on Friday, October 18th. Finally, Redburn Atlantic raised shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and raised their price target for the company from $380.00 to $510.00 in a research report on Friday, August 2nd. One analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have given a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $513.74.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.